<DOC>
	<DOCNO>NCT00738153</DOCNO>
	<brief_summary>This observational study conduct Africa . The aim observational study evaluate efficacy incidence serious adverse drug reaction use insulin Levemir® normal clinical practice condition .</brief_summary>
	<brief_title>An Observational Study Efficacy Safety Subjects Using Levemir® Treatment Insulin Dependent Type 1 Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Any subject Type 1 Type 2 diabetes mellitus eligible study , include newlydiagnosed subject never receive insulin insulin analogue . The selection subject discretion individual physician Subjects unlikely comply protocol , e.g. , uncooperative attitude , inability return final visit Currently treat insulin detemir Previously enrol study Hypersensitivity insulin detemir excipients Pregnancy , breastfeeding , intention become pregnant judge use adequate contraceptive measure .</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>